A Bispecific Monoclonal Antibody Targeting Psl and PcrV for Chronic Pseudomonas Aeruginosa Infection in Patients With Bronchiectasis: Results From a Randomized, Double-Blind Placebo-Controlled Trial (GREAT-2)M.B. Long, James D. Chalmers, Eve Mcintosh et al.|American Journal of Respiratory and Critical Care Medicine|2025Cited by 8
Proteinase 3 as a marker of clinical severity in bronchiectasis: Data from the EMBARC-BRIDGE studyEmma Johnson, James D. Chalmers, Megan Crichton et al.|Unknown|2023Cited by 2
Sputum proteomics uncovers the heterogeneity of Pseudomonas aeruginosa infections in bronchiectasisRebecca C Hull, James D. Chalmers, Jamie Stobo et al.|Unknown|2024Cited by 1
Airway CD10/neprilysin is related to lung function and disease severity in patients with bronchiectasis: Preliminary data from the EMBARC BRIDGE studyHannah Dickson, James D. Chalmers, Rebecca C Hull et al.|Unknown|2025Cited by 0
Distinct IL-1β and TNF driven inflammatory responses in Non-typable Haemophilus influenzae infection in bronchiectasisJames D. Chalmers, Rebecca C Hull, Hollian Richardson et al.|Unknown|2025Cited by 0